Case Study: ICER Reviews

Situation

A digital therapeutics and a gene therapy company required support on ICER reviews of their respective products

Objective

To support each partner by ensuring that their products receive a fair and favorable ICER assessment

Solution

Develop an ICER response plan based on each partner’s internal strategy, and effectively communicate criticisms to ICER’s evidence assessment and modeling approaches

Impact

Both products received favorable clinical evidence ratings and favorable reversals in cost-effectiveness between draft and final evidence reports